@article {959416, title = {Clinical Components of Telemedicine Programs for Diabetic Retinopathy.}, journal = {Curr Diab Rep}, volume = {16}, number = {12}, year = {2016}, month = {2016 Dec}, pages = {129}, abstract = {Diabetic retinopathy is a leading cause of new-onset vision loss worldwide. Treatments supported by large clinical trials are effective in preserving vision, but many persons do not receive timely diagnosis and treatment of diabetic retinopathy, which is typically asymptomatic when most treatable. Telemedicine evaluation to identify diabetic retinopathy has the potential to improve access to care, but there are no universal standards regarding camera choice or protocol for ocular telemedicine. We review the literature regarding the impact of imaging device, number and size of retinal images, pupil dilation, type of image grader, and diagnostic accuracy on telemedicine assessment for diabetic retinopathy. Telemedicine assessment of diabetic retinopathy has the potential to preserve vision, but further development of telemedicine specific technology and standardization of operations are needed to better realize its potential.}, issn = {1539-0829}, doi = {10.1007/s11892-016-0813-8}, author = {Horton, Mark B and Silva, Paolo S and Cavallerano, Jerry D and Aiello, Lloyd Paul} }